Role of the renin-angiotensin system in the development thyroxine-induced hypertension

被引:20
作者
delRio, CG
Moreno, MRR
Osuna, A
Luna, JD
GarciaEstan, J
Vargas, F
机构
[1] FAC MED GRANADA, DEPT FISIOL, E-18012 GRANADA, SPAIN
[2] FAC MED GRANADA, DEPT BIOESTADIST, E-18012 GRANADA, SPAIN
[3] U EXPT VIRGEN NIEVES, SERV NEFROL, GRANADA, SPAIN
[4] UNIV MURCIA, FAC MED, DEPT FISIOL, E-30100 MURCIA, SPAIN
[5] UNIV MURCIA, FAC MED, DEPT BIOESTADIST, E-30100 MURCIA, SPAIN
关键词
D O I
10.1530/eje.0.1360656
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We evaluated the influence of chronic blockade of the renin-angiotensin system on hypertension induced by long-term thyroxine (T-4) administration. To this end, we determined the effects of chronic treatment with captopril on blood pressure, cardiac hypertrophy and other renal and metabolic variables of hypertensive hyperthyroid rats. Methods: T-4 was administered s.c. at 0.38 mu mol/kg per day and captopril was given in the drinking water (1.38 mmol/l). Both treatments were maintained for 6 weeks. Control rats received tap water, After the treatment period, the rats were placed in metabolic cages. Later, blood pressure was measured in conscious rats by intra-arterial determination. Results: T-4-treated rats showed an increased mean arterial pressure (MAP) whereas, in rats treated with T-4 plus captopril, MAP was similar to that of the control group, Captopril did not affect the increased heart rate or ventricular weight/body weight ratio of hyperthyroid rats, but it improved the reduced creatinine clearance of these animals. Conclusions: The elevation in blood pressure produced by long-term T-4 administration was prevented by chronic blockade of the renin-angiotensin system, Captopril improved the renal function of hyperthyroid rats, but did not affect the relative cardiac hypertrophy of these animals.
引用
收藏
页码:656 / 660
页数:5
相关论文
共 28 条
[1]  
BEAVEN MA, 1963, LIFE SCI, P241
[2]  
BEDOTTO JB, 1989, J PHARMACOL EXP THER, V248, P632
[3]   THYROID AND KIDNEY [J].
BRADLEY, SE ;
STEPHAN, F ;
COELHO, JB ;
REVILLE, P .
KIDNEY INTERNATIONAL, 1974, 6 (05) :346-365
[4]   PLASMA CATECHOLAMINE CONCENTRATIONS IN HYPERTHYROIDISM AND HYPOTHYROIDISM [J].
COULOMBE, P ;
DUSSAULT, JH ;
WALKER, P .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1976, 25 (09) :973-979
[5]   EFFECT OF HYPERTHYROIDISM ON RENAL CONCENTRATING MECHANISM IN HUMANS [J].
CUTLER, RE ;
GLATTE, H ;
DOWLING, JT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1967, 27 (04) :453-+
[6]   FACTORS INVOLVED IN THE PATHOGENESIS OF HYPERTENSIVE CARDIOVASCULAR HYPERTROPHY - A REVIEW [J].
DAHLOF, B .
DRUGS, 1988, 35 :6-26
[7]  
FERRONE RA, 1979, EUR J PHARMACOL, V60, P131, DOI 10.1016/0014-2999(79)90211-5
[8]   KIDNEY FUNCTION IN VARIOUS THYROID STATES [J].
FORD, RV ;
MOYER, JH ;
CURD, GW ;
SPURR, CL ;
OWENS, JC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1961, 21 (05) :548-+
[9]   THYROID-HORMONES AND RENIN SECRETION [J].
GANONG, WF .
LIFE SCIENCES, 1982, 30 (7-8) :561-569
[10]   INVOLVEMENT OF RENIN-ANGIOTENSIN SYSTEM IN THE REDUCED PRESSURE NATRIURESIS RESPONSE OF HYPERTHYROID RATS [J].
GARCIAESTAN, J ;
ATUCHA, NM ;
QUESADA, T ;
VARGAS, F .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1995, 268 (05) :E897-E901